We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,635

Federal Court finds Expert Blinding to be One Factor in Assessing Weight Given to Expert Evidence
  • PCK Perry + Currier Inc Currier + Kao LLP
  • Canada
  • September 19 2017

When using expert witnesses in patent litigation, blinding them to the legal framework may be viewed favourably, however, it is only one of perhaps


Inutility finding overturned by Federal Court of Appeal in first application of Supreme Court’s Esomeprazole decision
  • Gowling WLG
  • Canada
  • September 22 2017

The Federal Court of Appeal's (FCA) first application of the Supreme Court of Canada's (SCC) decision in AstraZeneca Canada v Apotex


Canada Introduces Patent Term Extensions For Pharmaceutical Patents
  • Marks & Clerk
  • Canada
  • September 8 2017

For the first time, Canada has introduced sui generis patent term restoration for up to two years for patents relating to human and veterinary drugs


CETA Implementation: New Era of Pharmaceutical Patent Litigation Begins
  • McCarthy Tétrault LLP
  • Canada, European Union
  • September 21 2017

The provisional application of CETA takes effect in Canada today, ushering in a new era for pharmaceutical patent litigation. As part of this


Pharma and Biologic Disputes in Canada - New Regulations Take Effect September 21, 2017
  • Bennett Jones LLP
  • Canada
  • September 14 2017

Pharma and biologics manufacturers will soon have big decisions to make regarding their pharmaceutical and biological product strategy in Canada. On


April 2017 International Trade Compliance Update
  • Baker McKenzie
  • Canada, European Union, United Kingdom, USA
  • April 12 2017

The WTO announced that WTO members discussed five new or enhanced proposals to advance services negotiations at meetings of the Working Party on


CIALIS Patent Survives Validity Challenge on Appeal
  • McCarthy Tétrault LLP
  • Canada
  • May 19 2016

Last year we wrote about a trilogy of Federal Court decisions relating to Eli Lilly’s erectile dysfunction (ED) drug CIALIS (tadalafil). While Lilly


International Trade Compliance Update - September 2016
  • Baker McKenzie
  • Australia, Canada, European Union, United Kingdom, USA
  • September 7 2016

On 19 August 2016, the Russian Federation notified the WTO that it intends to initiate negotiations pursuant to Paragraph 1143 of the Working Party


December 2016 International Trade Compliance
  • Baker McKenzie
  • Global, OECD, United Kingdom, USA, Australia, Canada, European Union
  • December 12 2016

On 29 November 2016, the WTO reported that most WTO members welcomed Ecuador’s efforts to lower its import surcharge rates and reduce the number of


Government of Canada finalizes amended NOC Regulations and new CSP Regulations
  • Gowling WLG
  • Canada
  • September 11 2017

The Government of Canada has finalized the Certificate of Supplementary Protection Regulations (the "CSP Regulations") and the amended Patented